Michael Pfeifer
Overview
Explore the profile of Michael Pfeifer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
172
Citations
3860
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mohr A, Mercado M, Sicker N, Zahn S, Pfeifer M, Malfertheiner M, et al.
Dtsch Arztebl Int
. 2025 Feb;
121(26):884-885.
PMID: 39945341
No abstract available.
2.
Lepiorz M, Baier J, Veith M, Greulich T, Pfeifer M
Respir Med Case Rep
. 2024 Sep;
51:102097.
PMID: 39286412
This report describes family members with alpha-1 antitrypsin (AAT) deficiency arising from two rare alleles of - p.(Phe76del) and p.(Asp280Val) along with the more common deficiency allele, Pi*Z. The index...
3.
Seppala P, Pfeifer M, Toikko T
Soc Work Public Health
. 2024 Sep;
39(8):854-869.
PMID: 39221525
Child maltreatment seriously affects children's psychological and social well-being, as well as their physical health. The study aimed to explore the impact of violence experienced by children on their self-rated...
4.
Mohr A, Zahn S, Geismann F, Blaas S, Pfeifer M, Malfertheiner M, et al.
Pneumologie
. 2024 Jul;
PMID: 39079695
Introduction: Face masks increase airway resistance, data on the actual extent of this effect are scarce. The aim of this study was to assess the effect of different mask types...
5.
Geismann F, Brueckner K, Pfeifer M, Salzberger B, Bauernfeind S, Hitzenbichler F, et al.
Biomed Hub
. 2024 Jul;
9(1):67-72.
PMID: 39015199
Introduction: Invasive pneumococcal disease is a major cause of morbidity and mortality in infectious diseases. Selective reporting of antibiotic susceptibility test results might lead to a tailored antibiotic therapy and...
6.
Buschulte K, Kabitz H, Hagmeyer L, Hammerl P, Esselmann A, Wiederhold C, et al.
Respir Res
. 2024 Mar;
25(1):113.
PMID: 38448953
Background: Interstitial lung diseases (ILD) comprise a heterogeneous group of mainly chronic lung diseases with different disease trajectories. Progression (PF-ILD) occurs in up to 50% of patients and is associated...
7.
Skowasch D, Bonella F, Buschulte K, Kneidinger N, Korsten P, Kreuter M, et al.
Pneumologie
. 2024 Feb;
78(3):151-166.
PMID: 38408486
The present recommendations on the therapy of sarcoidosis of the German Respiratory Society (DGP) was written in 2023 as a German-language supplement and update of the international guidelines of the...
8.
Buschulte K, Kabitz H, Hagmeyer L, Hammerl P, Esselmann A, Wiederhold C, et al.
Respir Res
. 2024 Jan;
25(1):5.
PMID: 38178212
Background: Interstitial lung diseases (ILD) comprise a heterogeneous group of mainly chronic lung diseases with more than 200 entities and relevant differences in disease course and prognosis. Little data is...
9.
Baumert M, Linz D, Pfeifer M, Tafelmeier M, Felfeli P, Arzt M, et al.
ESC Heart Fail
. 2023 Oct;
10(6):3725-3728.
PMID: 37794711
Aims: This study aimed to assess the effectiveness of adaptive servo-ventilation (ASV) for lowering hypoxaemic burden components in heart failure with reduced ejection fraction (HFrEF) patients. Methods And Results: Fifty-six...
10.
Freitag-Wolf S, Schupp J, Frye B, Fischer A, Anwar R, Kieszko R, et al.
Front Med (Lausanne)
. 2023 Aug;
10:1218106.
PMID: 37621457
Introduction: Sarcoidosis is a highly variable disease in terms of organ involvement, type of onset and course. Associations of genetic polymorphisms with sarcoidosis phenotypes have been observed and suggest genetic...